Loading clinical trials...
Loading clinical trials...
To describe the effectiveness, treatment patterns, quality of life, and safety of participants with moderately or severely active UC treated with filgotinib in a real-world setting.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alfasigma S.p.A.
NCT04844606 · Ulcerative Colitis, Ulcerative Colitis Chronic, and more
NCT07550673 · Acute Severe Ulcerative Colitis
NCT06372613 · Ulcerative Colitis in Histologic Remission
NCT07374471 · Ulcerative Colitis (UC)
NCT05739864 · Active Ulcerative Colitis
LKH - Universitätsklinikum Graz
Graz
Klinikum Klagenfurt am Wörthersee
Klagenfurt
KH der Barmherzigen Brüder St.Veit an der Glan
Sankt Veit an der Glan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions